Company Filing History:
Years Active: 2015
Title: Chaur-Jong Hu: Innovator in Neurodegenerative Disorder Treatments
Introduction
Chaur-Jong Hu is an inventor based in Taipei City, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative disorders. His innovative approach focuses on utilizing a unique pharmaceutical composition that aims to improve cognitive dysfunction in affected individuals.
Latest Patent Applications
Chaur-Jong Hu's notable patent application is titled "Pharmaceutical Composition and Method for Treating Neurodegenerative Disorders Utilising the Pharmaceutical Composition." This application presents a pharmaceutical composition designed for treating neurodegenerative diseases of the brain. The composition includes cells encapsulated by microtubular array membranes (MTAMs), made from materials such as Polysulfone (PSF) or PLGA-PLLA copolymer. The cells involved in this composition consist of hybridoma cells capable of secreting anti-Tau antibodies or human umbilical cord mesenchymal stem cells (hUC-MSCs). The proposed pharmaceutical composition can be implanted into a living body to treat neurodegenerative diseases, ultimately aiming to enhance cognitive function in subjects in need.
Conclusion
Chaur-Jong Hu's work represents a promising advancement in the treatment of neurodegenerative disorders, showcasing innovative methods that could lead to significant improvements in patient care. His contributions to pharmaceutical compositions highlight the potential for new therapies in this critical area of health.